2020 ASCO Virtual Direct™ Highlights


 

2020 ASCO Highlights on CRC: Can We Consider Pembrolizumab a New First Line SoC in Patients With MSI-H mCRC?

559 views
July 14, 2020
Comments 0
Login to view comments. Click here to Login